FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt
Published
Infamous ex-pharmaceutical executive Martin Shkreli is yet again in trouble with the Federal Trade Commission, which announced today that the convicted fraudster has failed to cooperate with the commission's investigation into whether he violated his lifetime ban from the pharmaceutical industry…
#martinshkreli #druglikeinc #ftc #shkreli #martinshkrelis #hollyvedova #bureauofcompetition #daraprim #denisecote